H.R. 6038 (102nd): To amend title 35, United States Code, to permit separate patent extensions for each product under a patent which is subject to full regulatory review and approval.


Sep 25, 1992
102nd Congress, 1991–1992

Died in a previous Congress

This bill was introduced on September 25, 1992, in a previous session of Congress, but was not enacted.


Meldon Levine

Representative for California's 27th congressional district


About the bill

Summary (CRS)

9/25/1992--Introduced.Amends Federal patent law to permit separate patent extensions for certain drug products: (1) under a patent which is subject to full regulatory review and approval; and (2) which were ... Read more >

The bill’s title was written by its sponsor.


Sep 25, 1992

This is the first step in the legislative process.

This is a House of Representatives bill in the United States Congress (indicated by the “H.R.” in “H.R. 6038”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.


Committee Assignments

The committee chair determines whether a bill will move past the committee stage.


There have been no roll call votes related to this bill.

Find Similar Bills

Search for similar bills.

Links & tools

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.


Click a format for a citation suggestion: